Aaron’s practice focuses on patent litigation and counseling, with an emphasis on the life sciences and biotechnology. His experience includes matters before the federal courts and the U.S.  International Trade Commission. Aaron leverages his scientific background to assist clients with biosimilars proceedings, litigation under the Hatch-Waxman Act, and advocacy before the Food and Drug Administration.

David Pearl, a partner with extensive experience in both the private sector and government, uses his expertise to help technology companies and other clients navigate complex antitrust challenges. He represents clients in high-stakes litigations and investigations by the Department of Justice, Federal Trade Commission, and international competition authorities across Europe, Australia, Japan, Canada, Mexico, Brazil, and beyond. David also provides strategic guidance on cross-border merger reviews, addressing both antitrust concerns and foreign direct investment issues.

Jeannine Sano is a nationally recognized first-chair trial lawyer with 30 years of experience handling patent and trade secret trials and appeals in intellectual property venues across the country.  Her trial successes have been recognized by IAM Patent 1000, Managing IP, The Recorder, Daily Journal, and Benchmark Litigation, among other publications and awards.  She previously served as Chair of the Patent Litigation and ITC Practice Committees of the ABA Section of Intellectual Property. She is a frequent instructor at NITA, teaching trial advocacy skills to practicing attorneys, and serves as a judge for the American Mock Trial Competition and the Federal Bar Association’s Moot Court Competition.

James (“Jimmy”) Attridge is an antitrust partner trusted to guide clients through cartel investigations, antitrust litigation, and complex merger reviews. With deep government experience across multiple administrations – including as chief of staff for the U.S. Department of Justice (DOJ) Antitrust Division and a federal prosecutor – Jimmy has helped clients successfully navigate some of the most challenging government investigations and litigation.

John Bogert is an associate in Axinn's Antitrust group. His practice focuses on merger analysis, government investigations, and antitrust counseling.

Julie Chodos is the chief marketing and business development officer at Axinn, where she partners with firm leadership and all stakeholders to enhance market prominence and drive revenue growth through client strategy, relationship building, and brand positioning.

Aaron’s practice focuses on patent litigation and counseling, with an emphasis on the life sciences and biotechnology. His experience includes matters before the federal courts and the U.S.  International Trade Commission. Aaron leverages his scientific background to assist clients with biosimilars proceedings, litigation under the Hatch-Waxman Act, and advocacy before the Food and Drug Administration.

David Pearl, a partner with extensive experience in both the private sector and government, uses his expertise to help technology companies and other clients navigate complex antitrust challenges. He represents clients in high-stakes litigations and investigations by the Department of Justice, Federal Trade Commission, and international competition authorities across Europe, Australia, Japan, Canada, Mexico, Brazil, and beyond. David also provides strategic guidance on cross-border merger reviews, addressing both antitrust concerns and foreign direct investment issues.